BIVI - biovieinc.com Annual Revenue Growth (Last Twelve Months)

Brandmark of biovieinc.com (BIVI)

BioVie Inc. is a biopharmaceutical startup focused on environmental compliance during clinical testing. The company's TTM annual revenue growth rate links operational success to fundamentals, where the 0.00 level reflects the current magnitude. The business targets the fight against neurodegeneration in specialized clinics, developing proprietary therapies for the treatment of liver and brain pathologies.

BioVie Pharma (BIVI) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/18/2026

BioVie (BIVI) - metric breakdowns and financial figures

- stock price and consensus target price:
Fundamental company valuation:biovieinc.com
Signature product of biovieinc.com

Year-over-year sales growth (TTM) reflects the rolling annual revenue trend, accounting for adjustments between GAAP and Non-GAAP standards. This metric allows investors to decouple actual market demand from accounting revaluations. By analyzing the TTM annual sales growth chart, one can assess the sustainability of the asset's capitalization. For BioVie Inc. (BIVI), this indicator confirms the effectiveness of investments in leading neurobiologists. The researchers' breakthrough discoveries must now translate into commercial success.